Melanie F. Myers

Melanie F. Myers

Auto-generated profile, based on publicly available information

Melanie F. Myers

Division of Human Genetics Cincinnati Children's Hospital Medical Cincinnati Ohio USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SSSaskia Sanderson
Saskia Sanderson
KBKyle B. Brothers
Kyle B. Brothers
NMNathaniel D. Mercaldo
Nathaniel D. Mercaldo
ECEllen Wright Clayton
Ellen Wright Clayton
AAArmand H. Matheny Antommaria
Armand H. Matheny Antommaria
IHIngrid Adele Holm
Ingrid Adele Holm

1 January 2008 in Genetics
Verified
Journal Article
Closed access
BBBethany Vice Bowling
Bethany Vice Bowling
EAErin E Acra
Erin E Acra
LWLihshing Wang
Lihshing Wang
MMMelanie F Myers
Melanie F Myers
GDGary E Dean
Gary E Dean
CHCarl A Huether
Carl A Huether
There is continued emphasis on increasing and improving genetics education for grades K–12, for medical professionals, and for the general public. Another critical audience is undergraduate students in introductory biology and genetics courses. To improve the learning of genetics, there is a need to first assess students' understanding of genetics concepts and their level of genetics literacy (i.e., genetics knowledge as it relates to, and affects, their lives). We have developed and evaluated a new instrument to assess the genetics literacy of undergraduate students taking introductory biology or genetics courses. The Genetics Literacy Assessment Instrument is a 31-item multiple-choice test that addresses 17 concepts identified as central to genetics literacy. The items were selected and modified on the basis of reviews by 25 genetics professionals and educators. The instrument underwent additional analysis in student focus groups and pilot testing. It has been evaluated using ∼400 students in eight introductory nonmajor biology and genetics courses. The content validity, discriminant validity, internal reliability, and stability of the instrument have been considered. This project directly enhances genetics education research by providing a valid and reliable instrument for assessing the genetics literacy of undergraduate students.

1 September 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
HZHana Zouk
Hana Zouk
EVEric Venner
Eric Venner
NLNiall J. Lennon
Niall J. Lennon
DMDonna M. Muzny
Donna M. Muzny
DADebra Abrams
Debra Abrams
RGRichard A. Gibbs
Richard A. Gibbs

1 June 2006 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
MMMelanie F. Myers
Melanie F. Myers
MCMan-Huei Chang
Man-Huei Chang
CJCynthia Jorgensen
Cynthia Jorgensen
WWWilliam Whitworth
William Whitworth
SKSidibe Kassim
Sidibe Kassim
LBLinda A. Bradley
Linda A. Bradley
Purpose: To assess the impact of direct-to-consumer marketing of genetic testing for risk of breast and ovarian cancer by a biotechnology company on: 1) physicians' knowledge; 2) reasons given when asking questions about the test; and 3) physicians' practice patterns in two pilot cities where the campaign took place and two control cities. Methods: Survey of randomly selected family physicians, internists, obstetrician-gynecologists, and oncologists from May 1–May 21, 2003. Results: Physicians' knowledge did not differ between pilot and control cities. Significant differences (pilot versus control cities) were seen in the reasons patients gave for asking questions about testing. More physicians in pilot cities (14%) than control cities (7%) reported an increase in the number of times they ordered genetic testing for breast and ovarian cancer risk in the previous 6 months (adjusted odds ratio 1.9, 95% confidence interval, 1.2–3.1). Awareness of professional guidelines and being in a practice with a policy on genetic testing for risk of breast and ovarian cancer were associated with physicians' behaviors and interest among patients in testing. Conclusions: Given the complexity and limitations of genetic testing for risk of breast and ovarian cancer, the development and broad dissemination of clinical guidelines and education of physicians are needed.

1 December 2001 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MMMelanie F. Myers
Melanie F. Myers
SLSong Li
Song Li
ACAdolfo Correa-Villaseñor
Adolfo Correa-Villaseñor
ZLZhu Li
Zhu Li
CMCynthia A. Moore
Cynthia A. Moore
RBRobert Berry
Robert Berry
Maternal consumption of folic acid before pregnancy and during early pregnancy is associated with a reduced risk for some birth defects. Whether folic acid can reduce the risk for imperforate anus is unknown. As part of a public health campaign conducted in China from 1993 through 1995, the outcomes of pregnancies of ≥20 weeks' gestation were evaluated among women using folic acid supplements. The women were asked to take one pill containing 400 μg of folic acid (without other vitamins) every day from the time of their premarital examination until the end of their first trimester of pregnancy. Rates of imperforate anus and risk ratios for imperforate anus among the offspring of these women were calculated according to folic acid use. Among the offspring of women who took folic acid and women who did not take folic acid, 20 and 30 infants with imperforate anus were identified, respectively. The rate of imperforate anus was 3.1 per 10,000 among the offspring of women who did not take folic acid and 1.6 per 10,000 among the offspring of women who took folic acid; adjusted for maternal age, the risk ratio was 0.59 (95% confidence interval: 0.33, 1.07). Daily maternal consumption of 400 μg of folic acid before and during early pregnancy may reduce the risk for imperforate anus.

28 May 2018 in Journal of Empirical Research on Human Research Ethics
Verified
Journal Article
Closed access
MMMichelle L. McGowan
Michelle L. McGowan
CPCynthia A. Prows
Cynthia A. Prows
MDMelissa DeJonckheere
Melissa DeJonckheere
WBWilliam B. Brinkman
William B. Brinkman
LVLisa Vaughn
Lisa Vaughn
MMMelanie F. Myers
Melanie F. Myers
Opportunities to participate in genomic sequencing studies, as well as recommendations to screen for variants in 59 medically actionable genes anytime clinical genomic sequencing is performed, indicate adolescents will increasingly be involved in decisions about learning secondary findings from genome sequencing. However, how adolescents want to be involved in such decisions is unknown. We conducted five focus groups with adolescents (2) and parents (3) to learn their decisional preferences about return of genomic research results to adolescents. Discussions about decisional preferences centered around three themes: feelings about receiving genomic risk information, adolescent involvement and capacity to participate in decision-making, and recommendations for parental versus collaborative decision-making. We address the contested space between parental duties to act in their children’s best interests when choosing which results to return and adolescents’ desires to make autonomous decisions. A collaborative decision-making approach is recommended for obtaining consent from adolescents and their parents for genome sequencing research.